B&A Therapeutics
  • HOME
  • About Us
  • Research
  • Clinical Trial
  • News
  • Contact
  • English
    • French

Posts made in 2016

Accueil | 2016

Bumetanide to Treat Parkinson Disease : A Report of 4 Cases

0
Par admin
2 March 2016
News
Bumetanide to Treat Parkinson Disease : A Report of 4 Cases

Relying on recent experimental data in 2 animal models of Parkinson disease (PD), we have tested…

En savoir plus

B&A Therapeutics, partner for the « basal ganglia, Parkinson’s disease and treatments » day

0
Par admin
2 January 2016
News
B&A Therapeutics, partner for the « basal ganglia, Parkinson’s disease and treatments » day

Last Friday, January 15th, 2016, a scientific meeting in honor of Constance Hammond, emeritus Research Director…

En savoir plus

Recent Posts

  • IBEN hosts a satellite conference at FENS 2022
  • Bumetanide to Treat Parkinson Disease : A Report of 4 Cases
  • B&A Therapeutics, partner for the « basal ganglia, Parkinson’s disease and treatments » day
  • Following a clinical trial on autism, a syrup to reduce Parkinson’s disease symptoms
  • Early hypersynchrony in juvenile PINK1(-)/(-) motor cortex is rescued by antidromic stimulation

Archives

  • April 2022
  • March 2016
  • January 2016
  • November 2015
  • May 2014

Our contact information :

Bâtiment Beret-Delaage
Zone Luminy Biotech, Case 922
163 Avenue de Luminy
13273 Marseille Cedex 09
  • Home
  • About us
  • Research
  • Clinical trial
  • News
  • Contact
  • Legal notice
TOUS DROITS RÉSERVÉS B&A THERAPEUTICS - Création site internet Aix-en-provence PUBLICOM